ELEX Biotech Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

ELEX Biotech General Information

Description

Operator of a drug development company intended to find cures for cardiovascular diseases. The company's service includes the development of small-molecule pharmaceutical drugs for the management and cure of cardiovascular diseases such as heart failure and arrhythmias, enabling physicians to offer effective treatments for heart-related diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 2828 Southwest Corbett Avenue
  • Suite 214B
  • Portland, OR 97201
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 2828 Southwest Corbett Avenue
  • Suite 214B
  • Portland, OR 97201
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ELEX Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 08-Feb-2024 Completed Out of Business
3. Grant 01-Jan-2015 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 21-Aug-2012 $971K Completed Generating Revenue
To view ELEX Biotech’s complete valuation and funding history, request access »

ELEX Biotech Patents

ELEX Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019243561-A1 Compounds for treatment of cardiac arrhythmias and heart failure Inactive 29-Mar-2018
CA-3093551-A1 Compounds for treatment of cardiac arrhythmias and heart failure Pending 29-Mar-2018
EP-3774734-A1 Compounds for treatment of cardiac arrhythmias and heart failure Inactive 29-Mar-2018
US-11427542-B2 Compounds for treatment of cardiac arrhythmias and heart failure Inactive 29-Mar-2018
US-20210139429-A1 Compounds for treatment of cardiac arrhythmias and heart failure Active 29-Mar-2018 C07D213/73
To view ELEX Biotech’s complete patent history, request access »

ELEX Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ELEX Biotech FAQs

  • When was ELEX Biotech founded?

    ELEX Biotech was founded in 2009.

  • Where is ELEX Biotech headquartered?

    ELEX Biotech is headquartered in Portland, OR.

  • What is the size of ELEX Biotech?

    ELEX Biotech has 7 total employees.

  • What industry is ELEX Biotech in?

    ELEX Biotech’s primary industry is Drug Discovery.

  • Is ELEX Biotech a private or public company?

    ELEX Biotech is a Private company.

  • What is ELEX Biotech’s current revenue?

    The current revenue for ELEX Biotech is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process